Shuwen Biotech is an integrated diagnostic company with offices in China and Germany. Founded on the principles of innovation, patent protection, and international collaboration, Shuwen established strategic partnerships with leading academic and commercial institutions to commercialize first-in-class diagnostic technologies and patents, and has developed a range of novel diagnostics in the fields of cancer and women’s health.
Shuwen has also developed quality companion diagnostics and provided central lab biomarker testing services to leading pharmaceutical developers and hospitals. Shuwen houses an in-house development team, CAP-accredited central labs, and GMP/ISO13485-certified IVD manufacturing facilities, all in line with global standards to continue to deliver transformational products and services to its customers globally and open new possibilities in the advancement of health. Innovative products are offered on the international market through Cerca Biotech GmbH, Shuwen’s European subsidiary in Berlin.
Business Center
R&D Center
Shuwen Biotech (Hangzhou) CO., LTD
Our branch in the city of Hangzhou houses the majority of Shuwen’s R&D teams and facilities, where first-in-kind IVD kits are developed and registered for marketing in China, Europe, and other markets. The R&D teams also develop LDT assays for use in our central labs to provide testing services in the China market.
Production Base
Shuwen Biotech (Xuancheng) CO., LTD
Shuwen Biotech (Xuancheng) Co., Ltd., as one of the production bases of Shuwen group, has passed ISO13485 certification and undertakes R&D and production and sales related to high-end characteristic molecular detection projects of maternal and fetal medicine.
Production Base
Lingzuo Medical CO., LTD
Lingzuo Med is engaged in research and development, as well as production and sales services related to tumor and reproductive infection line projects.
Diagnostic Market
Shuwen Health CO., LTD
Shuwen Health provides promotion services for medical laboratory and scientific research projects.
Global Market
Cerca Biotech GmbH
Cerca Biotech is the European subsidiary of Shuwen Biotech. Cerca is passionate about healthcare and is committed to offering leading innovations in oncology and women health to the world.
Lab Services
Guanz Diagnostic Laboratories
The third-party independent laboratory of Shuwen Biotech can provide high-quality clinical trial sample testing services for domestic/international innovative pharmaceutical enterprises,and also provide high-level third-party independent medical testing services for the majority of medical institutions,doctors and patients.
Honors & Certificates
Core Team
Shuwen was founded by Dr. Jay Z. Zhang, a former senior vice president of Myriad Genetics Inc., a well-known gene diagnosis company in the United States. Shuwen possess an international team composed of doctors and experts with rich experience of management and research and development in well-known molecular diagnosis enterprise, a management team familiar with patent operation and good at international cooperation, and a product development and promotion team from leading diagnostic enterprises in Europe and America.
Founder / Chairman
Jay Z. Zhang MS, JD
Mr. Zhang has over thirty years of experience in biotech industry spanning R&D, patent, legal and management. Before founding Shuwen Biotech, Mr. Zhang was Senior Vice President at Myriad Genetics Inc. in Salt Lake City responsible for IP policies and strategies, patent prosecution and enforcement, and technology licensing and alliances in the areas of diagnostics and pharmaceuticals. Prior to Myriad, Mr. Zhang was an attorney with Alston & Bird LLP, and previously worked as a research scientist at Merck & Co., Inc. He was also a co-founder of Niiki Pharma Inc., a New Jersey-based startup pharmaceutical development company. Mr. Zhang holds a J.D. from the University of North Carolina School of Law, a M.S. in biochemistry and molecular biology from Northwestern University, and a B.S. in genetics from Fudan University. Mr. Zhang is a registered patent attorney before the U.S. Patent and Trademark Office, and was actively involved in the “gene patenting case” in the European Patent Office and US courts. He is an Editorial Board Member of the Biotechnology Law Report, and also served as a Professor of IP Law at China Jiliang University Law School.
Co-founder / Director / President
Yan Zhang
Ms. Zhang has many years of comprehensive management experience in pharmaceutical enterprises, especially skilled in biotechnology enterprise operation, marketing and quality management. Ms. Zhang graduated from Dalian University and Dalian Medical University, and qualified as a genetic counselor with an experience as a obstetrics and gynecology clinical doctor.
Senior Vice President
Barclay Li, Ph.D.
Master of Medicine from Peking Union Medical College and Ph.D. in Molecular Biology from University of Greenwich; Dr. Li led product development at internationally renowned biotech company Genzyme Diagnostics and Thermo Fisher Scientific, and has accumulated rich experience in a complete chain including domestic and foreign cooperation, new project and technology evaluation, product development and transformation, clinical trials and registration, and clinical application.
Chief Bioinformatics Officer
Qichao Zhu Ph.D.
Doctor of Molecular Biology from Kansas State University, USA, Postdoctoral Fellow at Baylor College of Medicine. Dr. Zhu successively worked at Eli Lilly, Boehringer Ingelheim and Mount Sinai School of Medicine, focusing on cancer precision medicine, genetic disease screening, translational medicine, drug target/biomarker identification, next-generation genome sequencing data analysis, as well as bioinformatics data mining.
Chief Legal Officer
Jeff Chen
Mr. Chen has 15 years of experience as a Chinese lawyer and patent attorney with expertise in intellectual property. He graduated from Tsinghua University and Temple University in the US and was a Principal at Spruson & Ferguson in Beijing office before joining Shuwen.
Chief medical officer
Ada Yuan, M.S. (Med.)
Ms. Yuan is responsible for the Medical Department at Shuwen, focusing on IVD pre-clinical and clinical development and providing scientific support to the Marketing and Sales. Prior to Shuwen, Ms. Yuan has over fourteen years of experience in pharmaceutical industry with an expertise in the field of oncology. Ms. Yuan received her M.S. (Med.) in hematology from Fudan University, B.S. (Med.) in clinical medicine from Shandong University in China.
Marketing & Sales Director, Oncology
William Zhang
Mr. Zhang graduated from Peking Union Medical College and has more than 10 years of marketing experience in domestic medical device products, especially cancer diagnosis products. He has successfully launched many products in various fields such as medical devices, medical technology, drugs and so on.
Commercial Director, Cerca Biotech GmbH
Richard Hughes
Mr. Hughes graduated from Brunel University in UK and has over 20 years of marketing and sales experience in IVD market. He ever served as international sales manager at Oxford Immunotec UK, European market manager at Abbott, regional manager at Philips Company, senior vice president of international market sales at Critical Diagnostics, and sales director at Microvisk.
Clinical Director, Cerca Biotech GmbH
Vinicio Tassani
Mr. Tassani graduated from Padua University in Italy with a master’s degree in biology. He ever served as global market manager at Biosite/Alere/Abbott, and international market director at Myriad Genetics.
